AirSculpt Technologies, Inc. (AIRS)

Market Cap	352.73M +41.2%
Revenue (ttm)	151.84M -11.8%
Net Income	-11.22M
EPS	-0.18
Shares Out	70.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	471,752
Open	5.200
Previous Close	5.280
Day's Range	4.950 - 5.530
52-Week Range	1.510 - 12.000
Beta	2.34
Analysts	Hold
Price Target	4.50 (-10.0%)
Earnings Date	May 8, 2026

About AIRS

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an adv...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 29, 2021
• Employees: 363
• Stock Exchange: NASDAQ
• Ticker Symbol: AIRS
• Website: https://www.airsculpt.com

Financial Performance

In 2025, AirSculpt Technologies's revenue was $151.82 million, a decrease of -15.82% compared to the previous year's $180.35 million. Losses were -$11.67 million, 45.5% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for AIRS stock is "Hold." The 12-month stock price target is $4.5, which is a decrease of -10.00% from the latest price.

Price Target

$4.5

(-10.00% downside)

Analyst Consensus: Hold